Close X
Monday, December 2, 2024
ADVT 
International

WHO says Equatorial Guinea confirms 1st outbreak of Marburg

Darpan News Desk The Canadian Press, 13 Feb, 2023 01:58 PM
  • WHO says Equatorial Guinea confirms 1st outbreak of Marburg

Photo courtesy of IStock. 

DAKAR, Senegal (AP) — The World Health Organization says that Equatorial Guinea has confirmed its first-ever outbreak of Marburg disease, saying the Ebola-related virus is responsible for at least nine deaths in the tiny Western African country.

In a statement on Monday, the U.N. health agency confirmed the epidemic after samples from Equatorial Guinea were sent to a lab in Senegal to pinpoint the cause of disease after an alert from a local health official last week.

The WHO said there were currently nine deaths and 16 suspected cases with symptoms including fever, fatigue, diarrhea and vomiting. The agency said it was sending medical experts to help officials in Equatorial Guinea stop the outbreak and was also sending protective equipment for hundreds of workers.

Like Ebola, the Marburg virus originates in bats and spreads between people via close contact with the bodily fluids of infected people, or surfaces, like contaminated bed sheets. Without treatment, Marburg can be fatal in up to 88% of people.

The rare virus was first identified in 1967 after it caused simultaneous outbreaks of disease in laboratories in Marburg, Germany and Belgrade, Serbia. Seven people died who were exposed to the virus while conducting research on monkeys.

There are no authorized vaccines or drugs to treat Marburg, but rehydration treatment to alleviate symptoms can improve the chances of survival.

In a 2004 outbreak in Angola, Marburg killed 90% of 252 people infected. Last year, there were two reported Marburg deaths in Ghana.

MORE International ARTICLES

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent
Announcing the results on Monday, Moderna said it has submitted emergency use authorisation from the US Food and Drug Administration (FDA), to apply for a conditional marketing authorisation with the European Medicines Agency (EMA) and to progress with the rolling reviews, which have already been initiated with international regulatory agencies.

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent

WATCH: Why are Farmers Up in Arms Against India's Government ?

WATCH: Why are Farmers Up in Arms Against India's Government ?
Protest by thousands of farmers from Punjab and Haryana took place in New Delhi over the weekend entering its fifth day Monday as the farmers continue to showcase their displeasure against the Centre's new farm laws. 

WATCH: Why are Farmers Up in Arms Against India's Government ?

White House still planning holiday parties, despite warnings

White House still planning holiday parties, despite warnings
Monday's delivery of an 18-and-a-half foot tall Fraser fir by horse-drawn carriage signalled the kickoff of the usual array of White House holiday events that will include the annual turkey pardon and Christmas and Hanukkah events.

White House still planning holiday parties, despite warnings

3rd major COVID-19 vaccine shown to be effective and cheaper

3rd major COVID-19 vaccine shown to be effective and cheaper
The results are based on an interim analysis of trials in the U.K. and Brazil of a vaccine developed by Oxford University and manufactured by AstraZeneca.

3rd major COVID-19 vaccine shown to be effective and cheaper

Pfizer seeking emergency use of its COVID-19 vaccine in US

Pfizer seeking emergency use of its COVID-19 vaccine in US
The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.

Pfizer seeking emergency use of its COVID-19 vaccine in US

Some of Trump's trade legacy to linger under Biden

Some of Trump's trade legacy to linger under Biden
Future administrations, be they Democrat or Republican, are unlikely to forget the lessons of 2016 any time soon, a panel of trade experts agreed Thursday.

Some of Trump's trade legacy to linger under Biden